Page last updated: 2024-10-21

acebutolol and Lichen Planus

acebutolol has been researched along with Lichen Planus in 1 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Lichen Planus: An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a saw-tooth pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taylor, AE1
Hindson, C1
Wacks, H1

Other Studies

1 other study available for acebutolol and Lichen Planus

ArticleYear
A drug eruption due to acebutolol with combined lichenoid and lupus erythematosus features.
    Clinical and experimental dermatology, 1982, Volume: 7, Issue:2

    Topics: Acebutolol; Humans; Lichen Planus; Lupus Erythematosus, Discoid; Male; Middle Aged

1982